These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 28756280)

  • 1. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach.
    Leng D; Thanki K; Fattal E; Foged C; Yang M
    Int J Pharm; 2018 Sep; 548(2):740-746. PubMed ID: 28847667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery.
    Thanki K; Papai S; Lokras A; Rose F; Falkenberg E; Franzyk H; Foged C
    Pharm Res; 2019 Jan; 36(3):37. PubMed ID: 30623253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
    Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
    Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
    Thanki K; Zeng X; Foged C
    Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
    Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
    Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
    Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
    J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.
    de Groot AM; Thanki K; Gangloff M; Falkenberg E; Zeng X; van Bijnen DCJ; van Eden W; Franzyk H; Nielsen HM; Broere F; Gay NJ; Foged C; Sijts AJAM
    Mol Ther Nucleic Acids; 2018 Jun; 11():159-169. PubMed ID: 29858051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the nanostructure of small interfering RNA-loaded lipidoid-polymer hybrid nanoparticles.
    Aljabbari A; Lokras AG; Kirkensgaard JJK; Rades T; Franzyk H; Thakur A; Zhang Y; Foged C
    J Colloid Interface Sci; 2023 Mar; 633():907-922. PubMed ID: 36508398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
    Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
    J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
    Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
    Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanoparticles for siRNA delivery and gene silencing.
    Patil Y; Panyam J
    Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
    Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
    Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized fluorodendrimer-incorporated hybrid lipid-polymer nanoparticles for efficient siRNA delivery.
    Xiong Q; Li Y; Zhou K; Chen P; Guo H; Chen L; Ding J; Song T; Shi J
    Biomater Sci; 2020 Feb; 8(3):758-762. PubMed ID: 31965126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SiRNA drug delivery by biodegradable polymeric nanoparticles.
    Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
    J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.